Corey Goodman
InvestorManaging Partner at venBio Partners
San Francisco, California
Writes $20M – $30M checks · typically $25M
About
Corey Goodman pairs deep neuroscience expertise in neural wiring and axon guidance molecules with hands-on company building—founding eight biotechs including Exelixis and leading Pfizer's Biotherapeutics to align science with pharma acquisition needs.
Invests in
BiotechHealthtech
Experience
- venBio PartnersManaging Partner
Deals · 3
AttralusBoard seat
via venBio Partners · filed Sep 2021 · $116.6M raise
Tallac Therapeutics, Inc.Board seat
via venBio Partners · filed Jul 2021 · $61.6M raise
Alexo TherapeuticsBoard seat
via venBio Partners · filed May 2015 · $36M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at venBio Partners
Aaron Royston
Managing Partner at venBio Partners
Daniel Teichmann
Controller at venBio Partners
David Pezeshki
Chief Financial Officer at venBio Partners
Jaume Pons
Venture Partner at venBio Partners
Parthiv Patel
Analyst at venBio Partners
Richard Gaster
Managing Partner at venBio Partners
Robert Adelman
Co-founder and Emeritus Managing Partner at venBio Partners
Yvonne Yamanaka
Partner at venBio Partners
Network5
Aaron Royston
Managing Partner at venBio Partners
Elena Viboch
Managing Director at General Catalyst
Jaume Pons
Venture Partner at venBio Partners
Richard Gaster
Managing Partner at venBio Partners
Yvonne Yamanaka
Partner at venBio Partners
Investors connected to Corey in public investor directories — a warm-intro map.